RetinAI

🔬 New Research: AI-Driven OCT Biomarkers for Choroidal Neovascularization Assessment We’re thrilled to share that our latest research article “𝘈𝘐-𝘋𝘳𝘪𝘷𝘦𝘯 𝘖𝘊𝘛 𝘉𝘪𝘰𝘮𝘢𝘳𝘬𝘦𝘳𝘴 𝘧𝘰𝘳 𝘊𝘩𝘰𝘳𝘰𝘪𝘥𝘢𝘭 𝘕𝘦𝘰𝘷𝘢𝘴𝘤𝘶𝘭𝘢𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘈𝘴𝘴𝘦𝘴𝘴𝘮𝘦𝘯𝘵 𝘪𝘯 𝘗𝘶𝘯𝘤𝘵𝘢𝘵𝘦 𝘐𝘯𝘯𝘦𝘳 𝘊𝘩𝘰𝘳𝘰𝘪𝘥𝘰𝘱𝘢𝘵𝘩𝘺 𝘢𝘯𝘥 𝘔𝘶𝘭𝘵𝘪𝘧𝘰𝘤𝘢𝘭 𝘊𝘩𝘰𝘳𝘰𝘪𝘥𝘪𝘵𝘪𝘴” has been officially published in the American Journal of Ophthalmology! 🎉 This work is the result of a successful collaboration between RetinAI and Prof. Marion Munk, M.D., Ph.D. (Augenarzt-Praxisgemeinschaft Gutblick AG), demonstrating on a cohort of 156 patients how our OCT Segmentation models enable AI-powered OCT analysis to identify key biomarkers involved in choroidal neovascularization (CNV) development in patients with punctate inner choroidopathy (PIC) and multifocal choroiditis (MFC). 𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬: 🔹 Increased lesion volume at baseline and longer disease duration were significantly associated with the presence of CNV in patients with PIC and MFC. 🔹 Lower BCVA, thicker RT, thinner CC+CS, and thicker PR+RPE layers were linked to CNV presence. 🔹 AI-driven volumetric analysis can serve as a powerful tool for identifying patients at higher risk of CNV development. 👉 Read the full article here: https://lnkd.in/ed8sYurW 𝐑𝐞𝐭𝐢𝐧𝐀𝐈 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲® and our 𝐀𝐈-𝐛𝐚𝐬𝐞𝐝 𝐎𝐂𝐓 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐦𝐨𝐝𝐞𝐥𝐬 support key biomarker assessment to better understand disease mechanisms, get in touch to explore how we can support your clinic in research and clinical workflows 👉 https://lnkd.in/ezTYb2tM 👏 Congratulations to the RetinAI team (Joseph B., Adrian Kaufmann, Sandro De Zanet), Prof. Marion Munk, M.D., Ph.D, and all collaborators and contributors involved in this study for their outstanding work and dedication to advancing AI-driven ophthalmic research! #AIinOphthalmology #OCTAnalysis #RetinAI #Ikerian #MedicalImaging #OphthalmicResearch #ArtificialIntelligence #Biomarkers #RetinaResearch

AAO was a blast! Thanks to everyone who stopped by our booth, and to the Media MICE team for capturing the energy in this great video! Let's write the next chapter of our journey, together! #AAO2025 #MediaMICE #Retina #AIinOphthalmology

🎬 That’s a wrap from AAO 2025! What an incredible few days in Orlando, filled with innovation, collaboration, and inspiring conversations about the future of AI in ophthalmology. A huge thank-you to everyone who met with us at Eyecelerator, SAIVO, and AAO, joined our Exclusive Event at Topgolf, or stopped by our booth for a live demo with Heidelberg Engineering. Your energy and insights made this week truly special! #AAO2025 #Ophthalmology #AI #ClinicalTrials #Innovation #Retina #RetinAI #HeidelbergEngineering

⛳ What an incredible first day at AAO! A huge thank-you to everyone who joined us at Topgolf Orlando last night, an amazing evening of insights, innovation, and fun! 🎯 Special thanks to our speakers: Dr. David Eichenbaum , Dr. Arshad M. Khanani , and Dr. Omer Trivizki, for sharing their expertise and inspiring discussions on how AI is accelerating Candidate Identification in Ophthalmology. 👏 The energy is high, and we’re just getting started.✨ More exciting sessions and conversations are happening today and tomorrow. Make sure to catch our Live Demos with Heidelberg Engineering and see RetinAI Discovery® in Spectralis in action! See you at the booth #1634.

Yesterday at INNOVATE Retina, Dr. David Eichenbaum shared results from our Proof-of-Concept Study, demonstrating how AI-powered imaging workflows improved enrollment efficiency by >4-fold. And we’re just getting started. 👀 Tomorrow, Dr. Eichenbaum will be joined by Dr. Arshad M. Khanani and Dr. Omer Trivizki to dive deeper into how AI is enabling smarter and faster clinical trials, transforming how we bring new treatments to patients. Join us for an exclusive evening of high-level networking, golf ⛳, and cutting-edge AI insights. Last spots, register now 👉 https://lnkd.in/d-_8hYKy PS: Don’t forget to visit us at booth #1634, we’ve got some very exciting innovations to share! #AIinOphthalmology #ClinicalResearch #Retina #AAO2025 #Innovation #DigitalHealth #Ophthalmology

⏳ The Final Countdown is On! This week, RetinAI is bringing AI-driven innovation in Ophthalmology to Eyecelerator, SAIVO, and AAO in Orlando, and you don’t want to miss it. From private 1:1 meetings and live demos, to our exclusive evening event at Topgolf Orlando, here’s your chance to: ✅ Join Dr. David Eichenbaum, Dr. Arshad M. Khanani and Dr. Omer Trivizki to explore Smarter & Faster Clinical trials with AI ✅ See fully automated imaging workflows in action with RetinAI Discovery® and Heidelberg Engineering US Spectralis® at booth #1634 ✅ Connect with leading retina specialists shaping the future of ophthalmology Spots for private meetings and our evening event are filling fast! Let’s connect and discuss how we can collaborate to drive innovation. 👉https://lnkd.in/g4wkgQG9 #Ophthalmology #AI #ClinicalTrials #Innovation #Eyecelerator #SAIVO #AAO #RetinAI

We’re thrilled to share an important milestone in our journey, Ikerian, the parent company of RetinAI, has been acquired by EssilorLuxottica. From the very beginning, our mission has been to harness the power of data and AI to transform patient care. This next chapter with EssilorLuxottica allows us to take that mission even further - scaling our impact globally and deepening our contribution to the future of patient care. “Together with my co-founders, Stefanos Apostolopoulos and Sandro De Zanet, I am so proud of the team and excited about this incredible milestone for RetinAI. Joining EssilorLuxottica marks a defining moment in our journey. This partnership opens new opportunities to bring our vision to life at a completely new scale - shaping how technology drives better healthcare, sharper vision, and improved outcomes for patients.” Carlos Ciller, PhD, Chairman & CEO of RetinAI / Ikerian AG To our incredible team, partners, and community - thank you for your trust and support. This milestone belongs to all of you, and it’s only the beginning of what we can achieve together. 🔹 Visit us at #AAO25 in Orlando, booth #1634, to see what this next chapter means for AI-powered eyecare and experience our technology live. 👉 Read the full announcement here: https://lnkd.in/efum47VB #AIinHealthcare #Ophthalmology #RetinAI #Ikerian #EssilorLuxottica #RetinalImaging #MedTech #Innovation #VisionCare #AI

🚀 How to Boost Enrollment Efficiency by >4-fold in your next Clinical Trial in 3 steps ...and why you should join top Retina leaders: Dr. David Eichenbaum, Dr. Arshad M. Khanani, and Dr. Omer Trivizki for an exclusive Evening of AI, Innovation & Golf. We will reveal data from our Proof-of-Concept Study showing how AI-powered imaging workflows improved enrollment efficiency by >4-fold. Here’s a preview of what we’ll cover: ✅ Automated OCT data sync and AI analysis at your sites ✅ Automated filtering of imaging data by inclusion/exclusion criteria ✅ Reconcile imaging and EMR data for a quality-based candidate list 📅 Saturday, October 18, 2025 | 5 PM 📍 Topgolf Orlando, FL Last spots available. Reserve yours now 👉 https://lnkd.in/dGkaWgFK

🚨 Exclusive Evening of AI, Innovation & Golf at AAO - Last spots available! Join leading retina specialists Dr. David Eichenbaum, Dr. Arshad M. Khanani, and Dr. Omer Trivizki to discover how AI is enhancing candidate identification and optimizing clinical trial efficiency in retina research. Be part of an exclusive evening of thought leadership, visionary discussion, high-level networking and some golf fun! ⛳ 📅 Saturday, 18 Oct 2025 | 5 PM 📍 Topgolf Orlando, FL 🎯 Reserve your spot today: https://lnkd.in/dGkaWgFK #AAO #AI #ClinicalTrials #Retina